Harris, Katherine
LaBelle, James L.
Bishop, Michael R.
Article History
Accepted: 31 March 2021
First Online: 7 June 2021
Declarations
:
: Katherine Harris declares that she has no conflict of interest. James L. LaBelle declares that he has no conflict of interest. Michael R. Bishop has received research funding from Novartis, Kite Pharma/Gilead, and CRISPR Therapeutics and has received compensation for service as a consultant from Novartis, Kite Pharma/Gilead, Bristol-Myers Squibb/Juno Therapeutics, and Autolus Therapeutics.